| Literature DB >> 36002810 |
Shaowei Sun1, Shengbo Sun1, Xiangyun Zheng1, Jiangtao Yu1, Wenchang Wang1, Qing Gong1, Guowei Zhao1, Jing Li1, Huanhu Zhang2.
Abstract
BACKGROUND: Extralevator abdominoperineal excision (ELAPE) has been recommended for treating low rectal cancer due to its potential advantages in improving surgical safety and oncologic outcomes as compared to conventional abdominoperineal excision (APE). In ELAPE, however, whether the benefits of intraoperative position change to a prone jackknife position outweighs the associated risks remains controversial. This study is to introduce a modified position change in laparoscopic ELAPE and evaluate its feasibility, safety and the long-term therapeutic outcomes.Entities:
Keywords: Exralevator abdominoperineal resection; Long-term; Low rectal cancer; Position change; Survival analysis
Mesh:
Year: 2022 PMID: 36002810 PMCID: PMC9404665 DOI: 10.1186/s12885-022-10019-2
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.638
Fig. 1Perineal operative procedure. A incision range in the prone jackknife position, B rectum was separated to the upper rim of seminal vesicle in male patients, C the loop ligature of anus rectum was performed with a sterile specimen bag
Fig. 2The location of the trocars (trocar A 10 mm, trocar B 12 mm, trocar C, D and E 5 mm)
Fig. 3The pelvic peritoneum was directly closed by the laparoscopic approach. A, B the closure of pelvic peritoneum in the male patient; C, D the closure of pelvic peritoneum in the female patient
Patient characteristics
| Patient number | Gender | Age (years) | BMI (kg/m2) | ASA class | Distance to anal verge (cm) | Tumor size (cm) | Preoperative stage | nCRT |
|---|---|---|---|---|---|---|---|---|
| 1 | Male | 68 | 22.7 | 2 | 3 | 3 | cT2N1M0 | No |
| 2 | Female | 49 | 21.5 | 1 | 3 | 3.8 | cT3N0M0 | No |
| 3 | Male | 63 | 23.5 | 1 | 4 | 4 | cT3N2M0 | Yes |
| 4 | Male | 62 | 23.1 | 1 | 4 | 4 | cT3N2M0 | Yes |
| 5 | Female | 69 | 25.4 | 2 | 3 | 3 | cT3N0M0 | No |
| 6 | Female | 77 | 25.4 | 1 | 3.5 | 4.8 | cT3N0M0 | No |
| 7 | Male | 56 | 25.4 | 1 | 2 | 4 | cT3N0M0 | No |
| 8 | Male | 66 | 23.4 | 2 | 3.5 | 3.5 | cT3N0M0 | No |
| 9 | Male | 59 | 21.5 | 2 | 3 | 6 | cT3N0M0 | No |
| 10 | Male | 57 | 34.3 | 2 | 3 | 4.5 | cT3N2M0 | Yes |
| 11 | Male | 68 | 19.1 | 2 | 3 | 2 | cT2N0M0 | No |
| 12 | Male | 76 | 22.0 | 2 | 2 | 2.5 | cT3N2M0 | No |
| 13 | Male | 68 | 23.6 | 2 | 3 | 3.5 | cT3N2M0 | No |
| 14 | Female | 77 | 22.2 | 2 | 1 | 5 | cT3N2M0 | No |
| 15 | Female | 66 | 27.6 | 2 | 4 | 5 | cT4bN1M0 | No |
| 16 | Male | 58 | 25.9 | 1 | 4 | 3 | cT3N1M0 | No |
| 17 | Male | 56 | 21.3 | 1 | 1 | 4.5 | cT3N2M0 | No |
| 18 | Female | 72 | 22.1 | 2 | 3 | 5.5 | cT3N0M0 | No |
| 19 | Female | 52 | 23.4 | 1 | 3 | 2.5 | cT3N2M0 | No |
| 20 | Male | 66 | 23.7 | 1 | 3 | 3.5 | cT2N1M0 | No |
| 21 | Female | 66 | 27.1 | 2 | 1 | 1.5 | cT2N1M0 | No |
| 22 | Female | 57 | 21.3 | 2 | 3 | 3.5 | cT2N1M0 | No |
| 23 | Male | 54 | 26.7 | 1 | 3 | 3 | cT3N2M0 | Yes |
| 24 | Male | 49 | 22.6 | 1 | 4 | 6 | cT3N0M0 | No |
| 25 | Male | 73 | 21.2 | 2 | 4 | 5 | cT4N2M0 | Yes |
| 26 | Male | 40 | 23.7 | 1 | 5 | 4.8 | cT4N2M0 | Yes |
| 27 | Male | 69 | 20.3 | 2 | 3.5 | 4.5 | cT3N2M0 | Yes |
| 28 | Female | 72 | 23.2 | 2 | 1 | 7 | cT2N0M0 | No |
| 29 | Male | 66 | 26.3 | 1 | 2 | 8 | cT3N2M0 | No |
| 30 | Male | 65 | 23.0 | 1 | 4 | 4 | cT3N0M0 | No |
| 31 | Female | 69 | 24.0 | 3 | 3 | 4 | cT3N0M0 | No |
| 32 | Female | 75 | 22.4 | 1 | 4 | 6.2 | cT4N2M0 | Yes |
| 33 | Male | 78 | 20.6 | 2 | 2 | 3.7 | cT2N2M0 | No |
| 34 | Female | 66 | 23.2 | 2 | 4 | 3.8 | cT3N0M0 | No |
| 35 | Male | 75 | 23.5 | 2 | 1 | 3 | cT3N0M0 | No |
| 36 | Male | 57 | 20.8 | 2 | 5 | 3.8 | cT3N2M0 | No |
| 37 | Male | 63 | 22.2 | 1 | 3 | 3.6 | cT2N0M0 | No |
| 38 | Male | 35 | 22.5 | 1 | 3 | 5 | cT2N0M0 | No |
| 39 | Female | 55 | 22.5 | 1 | 3 | 3.5 | cT3N2M0 | Yes |
| 40 | Male | 47 | 21.3 | 1 | 4 | 2.5 | cT2N0M0 | No |
| 41 | Female | 67 | 21.4 | 2 | 3 | 2.6 | cT3N0M0 | No |
| 42 | Male | 58 | 27.7 | 2 | 4 | 3.5 | cT3N0M0 | No |
| 43 | Male | 62 | 22.9 | 1 | 1 | 3.5 | cT3N0M0 | No |
| 44 | Male | 58 | 17.3 | 1 | 1 | 7 | cT3N0M0 | No |
| 45 | Male | 83 | 19.6 | 2 | 2 | 2.7 | cT2N0M0 | No |
| 46 | Male | 69 | 25.1 | 2 | 2 | 5.5 | cT2N0M0 | No |
| 47 | Male | 66 | 21.8 | 2 | 3 | 3 | cT3N2M0 | Yes |
| 48 | Male | 58 | 23.0 | 1 | 2 | 2 | cT2N2M0 | Yes |
| 49 | Female | 69 | 26.1 | 2 | 2 | 5 | cT2N0M0 | No |
| 50 | Male | 56 | 26.1 | 1 | 3 | 7.3 | cT2N1M0 | No |
| 51 | Male | 67 | 29.4 | 1 | 3 | 1 | cT2N1M0 | No |
| 52 | Female | 60 | 26.7 | 2 | 2 | 3 | cT3N0M0 | No |
| 53 | Male | 59 | 26.0 | 1 | 4 | 5 | cT3N2M0 | Yes |
| 54 | Male | 69 | 23.9 | 1 | 3 | 3 | cT3N1M0 | Yes |
| 55 | Male | 64 | 23.7 | 2 | 3 | 1.7 | cT1N0M0 | No |
| 56 | Female | 71 | 22.9 | 1 | 4 | 4.5 | cT3N0M0 | No |
ASA American society of anesthesiologists, BMI body mass index, nCRT neoadjuvant chemoradiotherapy
Intraoperative and postoperative outcomes
| Patient number | Operative time (min) | Blood loss (ml) | Postope-rative hospital stay (days) | Days to first flatus | Days to urinary catheter removal | Days to 1st liquid diet | postoperative 30-day complications | Postoperative 30-day death | long-term complications |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 210 | 200 | 12 | 2 | 6 | 3 | No | No | No |
| 2 | 200 | 100 | 9 | 3 | 4 | 4 | No | No | No |
| 3 | 220 | 100 | 12 | 3 | 6 | 2 | No | No | No |
| 4 | 210 | 300 | 12 | 3 | 6 | 2 | No | No | No |
| 5 | 240 | 200 | 12 | 2 | 6 | 2 | No | No | Parastomal hernia |
| 6 | 240 | 200 | 12 | 3 | 6 | 3 | No | No | No |
| 7 | 200 | 200 | 8 | 2 | 6 | 1 | No | No | Decreased sexual function |
| 8 | 230 | 300 | 8 | 2 | 6 | 2 | No | No | No |
| 9 | 190 | 400 | 9 | 2 | 6 | 2 | No | No | No |
| 10 | 320 | 400 | 12 | 3 | 5 | 2 | No | No | parastomal hernia |
| 11 | 230 | 100 | 11 | 3 | 5 | 2 | No | No | No |
| 12 | 240 | 300 | 13 | 3 | 6 | 2 | No | No | No |
| 13 | 240 | 100 | 9 | 3 | 5 | 2 | No | No | No |
| 14 | 220 | 200 | 11 | 2 | 7 | 2 | No | No | No |
| 15 | 280 | 200 | 12 | 2 | 6 | 2 | No | No | No |
| 16 | 220 | 100 | 12 | 2 | 5 | 2 | No | No | No |
| 17 | 240 | 200 | 11 | 3 | 6 | 2 | No | No | No |
| 18 | 220 | 200 | 10 | 2 | 4 | 3 | No | No | N0 |
| 19 | 210 | 200 | 8 | 2 | 5 | 2 | No | No | No |
| 20 | 200 | 200 | 9 | 3 | 5 | 4 | No | No | No |
| 21 | 245 | 50 | 12 | 2 | 5 | 2 | No | No | parastomal hernia |
| 22 | 200 | 200 | 9 | 3 | 5 | 2 | No | No | No |
| 23 | 240 | 800 | 9 | 3 | 4 | 2 | No | No | No |
| 24 | 205 | 100 | 8 | 2 | 3 | 2 | No | No | No |
| 25 | 240 | 100 | 12 | 3 | 6 | 2 | No | No | No |
| 26 | 230 | 200 | 13 | 3 | 4 | 3 | No | No | No |
| 27 | 240 | 200 | 13 | 2 | 6 | 2 | No | No | No |
| 28 | 205 | 200 | 9 | 2 | 5 | 2 | No | No | No |
| 29 | 210 | 300 | 13 | 2 | 3 | 1 | No | No | No |
| 30 | 190 | 100 | 11 | 3 | 5 | 2 | No | No | No |
| 31 | 210 | 100 | 12 | 2 | 5 | 2 | No | No | No |
| 32 | 200 | 200 | 11 | 3 | 4 | 1 | No | No | No |
| 33 | 230 | 50 | 10 | 3 | 3 | 2 | No | No | No |
| 34 | 220 | 100 | 11 | 2 | 6 | 2 | No | No | No |
| 35 | 190 | 100 | 11 | 2 | 6 | 2 | No | No | No |
| 36 | 170 | 50 | 8 | 2 | 6 | 1 | No | No | No |
| 37 | 160 | 100 | 12 | 2 | 4 | 1 | No | No | No |
| 38 | 230 | 100 | 8 | 2 | 3 | 1 | No | No | No |
| 39 | 230 | 50 | 11 | 1 | 5 | 1 | No | No | No |
| 40 | 170 | 50 | 11 | 2 | 6 | 3 | No | No | No |
| 41 | 170 | 50 | 11 | 3 | 2 | 1 | No | No | No |
| 42 | 240 | 50 | 11 | 3 | 5 | 2 | No | No | No |
| 43 | 200 | 50 | 9 | 2 | 6 | 2 | No | No | No |
| 44 | 160 | 50 | 10 | 2 | 4 | 2 | No | No | No |
| 45 | 200 | 50 | 8 | 3 | 3 | 1 | No | No | No |
| 46 | 240 | 100 | 15 | 3 | 3 | 1 | No | No | No |
| 47 | 210 | 50 | 11 | 2 | 2 | 2 | No | No | No |
| 48 | 250 | 50 | 9 | 1 | 3 | 2 | No | No | No |
| 49 | 210 | 150 | 9 | 2 | 2 | 1 | No | No | No |
| 50 | 180 | 100 | 11 | 2 | 2 | 1 | No | No | No |
| 51 | 180 | 100 | 9 | 2 | 2 | 2 | No | No | No |
| 52 | 170 | 100 | 11 | 2 | 2 | 1 | No | No | Perineal hernia |
| 53 | 190 | 100 | 7 | 2 | 4 | 1 | No | No | No |
| 54 | 200 | 100 | 11 | 3 | 2 | 1 | No | No | No |
| 55 | 200 | 50 | 13 | 3 | 2 | 1 | No | No | No |
| 56 | 180 | 50 | 8 | 3 | 3 | 2 | No | No | No |
Pathologic and 5-year oncologic outcomes
| Patient number | Pathological stage | CRM | Differentiation degree | MAC | Venous or neural invasion | Local recurrence | Distant metastasis | Survival status |
|---|---|---|---|---|---|---|---|---|
| 1 | pT2N0M0 I | Negative | Well | No | No | No | No | Normal |
| 2 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 3 | ypT3N1bM0 IIIB | Negative | Moderately | No | No | No | Lung | Death |
| 4 | ypT3N1aM0 IIIB | Negative | Poorly | No | No | No | No | Normal |
| 5 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 6 | pT3N0M0 IIA | Negative | Well | No | No | No | No | Normal |
| 7 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 8 | pT2N0M0 I | Negative | Well | No | No | No | No | Normal |
| 9 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 10 | ypT3N2aM0 IIIB | Negative | Moderately | Yes | No | No | Lung | Death |
| 11 | pT1N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 12 | pT3N1bM0 IIIB | Negative | Poorly | No | Yes | No | Lung | Death |
| 13 | pT3N1aM0 IIIB | Negative | Moderately | No | Yes | No | No | Normal |
| 14 | pT3N0M0 IIA | Negative | Moderately | No | Yes | No | Lung | Death |
| 15 | pT4bN0M0 IIC | Negative | Moderately | No | No | No | No | Normal |
| 16 | pT3N0M0 IIA | Negative | Well | No | No | No | Lung and bone | Death |
| 17 | pT3N0M0 IIA | Negative | Moderately | Yes | No | No | No | Normal |
| 18 | pT2N0M0 I | Negative | Well | Yes | No | No | No | Death |
| 19 | pT2N0M0 I | Negative | Poorly | No | No | No | No | Normal |
| 20 | pT2N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 21 | pT1N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 22 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 23 | ypT3N2aM0 IIIB | Negative | Poorly | No | Yes | No | No | Normal |
| 24 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 25 | ypT3N2bM0 IIIC | Negative | Poorly | No | Yes | No | No | Death |
| 26 | ypT3N2bM0 IIIC | Negative | Poorly | No | Yes | No | Lung and bone | Death |
| 27 | ypT2N2aM0 IIIB | Negative | Moderately | No | No | No | Bone | Death |
| 28 | pT1N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 29 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 30 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 31 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 32 | ypT3N2bM0 IIIC | Negative | Poorly | No | Yes | No | Lung | Death |
| 33 | pT2N1aM0 IIIA | Negative | Moderately | No | No | No | No | Normal |
| 34 | pT4aN0M0 IIB | Negative | Moderately | No | No | No | Lung, liver and bone | Death |
| 35 | pT2N0M0 I | Negative | Moderately | No | No | No | Bone | Death |
| 36 | pT3N2aM0 IIIB | Negative | Moderately | No | Yes | No | Liver | Death |
| 37 | pT2N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 38 | pT2N0M0 I | Negative | Poorly | No | No | No | No | Normal |
| 39 | ypT3N2aM0 IIIB | Negative | Poorly | No | Yes | No | No | Normal |
| 40 | pT2N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 41 | pT3N0M0 IIA | Negative | Poorly | No | No | No | No | Normal |
| 42 | pT2N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 43 | pT3N0M0 IIA | Negative | Moderately | No | Yes | Yes | No | Death |
| 44 | pT2N0M0 I | Negative | Moderately | No | Yes | No | No | Death |
| 45 | pT3N0M0 IIA | Negative | Moderately | No | No | No | Liver and lung | Death |
| 46 | pT1N0M0 I | Negative | Poorly | No | No | No | No | Normal |
| 47 | ypT3N1aM0 IIIB | Negative | Poorly | No | No | No | No | Normal |
| 48 | ypT3N2aM0 IIIB | Negative | Well | Yes | Yes | No | No | LTFU |
| 49 | pT2N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 50 | pT3N0M0 IIA | Negative | Moderately | Yes | No | No | No | Normal |
| 51 | pT2N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 52 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
| 53 | ypT3N1aM0 IIIB | Negative | Moderately | No | No | No | No | Normal |
| 54 | ypT3N1aM0 IIIB | Negative | Moderately | No | No | No | No | Normal |
| 55 | pT1N0M0 I | Negative | Moderately | No | No | No | No | Normal |
| 56 | pT3N0M0 IIA | Negative | Moderately | No | No | No | No | Normal |
CRM circumferential resection margin, MAC mucinous adenocarcinoma, LTFU lost to follow-up
Fig. 4Kaplan-Meier curves showing overall and disease-free survival. A survival curves of overall survival. B survival curves of disease-free survival